STRATA Skin Sciences (SSKN) EBITDA Margin (2012 - 2025)
STRATA Skin Sciences' (SSKN) quarterly EBITDA Margin came in at 41.71% in Q4 2025, up 8646.0% year-on-year from 0.48% in Q4 2024, and up 346.4% quarter-over-quarter from 16.93% in Q3 2025.
STRATA Skin Sciences (SSKN) EBITDA Margin (2012 - 2025) Analysis & Trends
STRATA Skin Sciences has disclosed EBITDA Margin across 14 years of filings, most recently posting 41.71% for Q4 2025.
- EBITDA Margin for Q4 2025 came in at 41.71%, up 8646.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 4.27% (up 2330.0% YoY), and the FY2025 annual result was 4.27%, up 2330.0% from the prior year.
- EBITDA Margin came in at 41.71% for Q4 2025 at STRATA Skin Sciences, up from 16.93% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 41.71% in Q4 2025 to a low of 44.75% in Q4 2024.
- The 5-year median for EBITDA Margin is 18.43% (2022), against an average of 18.56%.
- Across the five-year window, EBITDA Margin slumped 4087 bps in 2023 and surged 8646 bps in 2025, its largest moves.
- STRATA Skin Sciences' EBITDA Margin stood at 6.87% in 2021, then jumped by 118 bps to 1.26% in 2022, then sank by 3233 bps to 39.6% in 2023, then decreased by 13 bps to 44.75% in 2024, then jumped by 193 bps to 41.71% in 2025.
- The last three EBITDA Margin figures came in at 41.71% (Q4 2025), 16.93% (Q3 2025), and 30.14% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 14.52% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 19.94% |
| 10 | STRATA Skin Sciences | - | - | 5.61 Mn | 41.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 41.71% |
| Sep 30, 2025 | -16.93% |
| Jun 30, 2025 | -30.14% |
| Mar 31, 2025 | -25.03% |
| Dec 31, 2024 | -44.75% |
| Sep 30, 2024 | -18.24% |
| Jun 30, 2024 | -5.67% |
| Mar 31, 2024 | -42.75% |
| Dec 31, 2023 | -39.60% |
| Sep 30, 2023 | -6.95% |
| Jun 30, 2023 | -23.78% |
| Mar 31, 2023 | -34.17% |
| Dec 31, 2022 | 1.26% |
| Sep 30, 2022 | -8.35% |
| Jun 30, 2022 | -18.61% |
| Mar 31, 2022 | -32.71% |
| Dec 31, 2021 | -6.87% |
| Sep 30, 2021 | -6.03% |
| Jun 30, 2021 | -12.50% |
| Mar 31, 2021 | -41.05% |